Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Percutaneous valve procedures: present and future.

Zamer Tawn1, Dominique Himbert, Eric Brochet

  • 1Bichat Hospital, Paris, France.

International Journal of Cardiovascular Interventions
|July 16, 2005
PubMed
Summary

Percutaneous mitral commissurotomy offers excellent results for mitral stenosis, largely replacing surgery. However, percutaneous aortic valvuloplasty is rarely used, while newer percutaneous valve interventions require further evaluation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survival outcomes in isolated severe tricuspid regurgitation according to therapeutic modalities: a systematic review and meta-analysis.

Open heart·2025
Same author

Hospitalization of Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation Treated With MitraClip: Insights From RESHAPE-HF2.

Journal of the American College of Cardiology·2024
Same author

Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation.

The New England journal of medicine·2024
Same author

Sex-related differences in severe native valvular heart disease: the ESC-EORP Valvular Heart Disease II survey.

European heart journal·2024
Same author

Management of Massive Thrombosis of a Tendyne Valve: The Importance of Heart Valve Centers.

JACC. Case reports·2024
Same author

Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials.

European journal of heart failure·2024

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Valvular Heart Disease

Background:

  • Percutaneous mitral commissurotomy (PMC) and percutaneous aortic valvuloplasty (PAV) have been performed since the mid-1980s.
  • PMC has demonstrated good short- and long-term outcomes, becoming the standard treatment for mitral stenosis.
  • PAV has seen limited global use due to efficacy and safety concerns.

Purpose of the Study:

  • To review the current status and future potential of percutaneous interventions for valvular heart disease.
  • To compare the established efficacy of PMC with the evolving landscape of PAV and newer percutaneous valve replacement and repair techniques.

Main Methods:

  • Review of historical and current data on percutaneous valvular interventions.
  • Analysis of outcomes and risks associated with balloon commissurotomy and newer percutaneous valve procedures.

Related Experiment Videos

  • Evaluation of the current role and future prospects of these minimally invasive techniques.

    • Main Results:

    • PMC is highly effective and has largely replaced surgical commissurotomy for mitral stenosis.
    • PAV has been largely abandoned due to poor efficacy and significant risks.
    • Newer percutaneous aortic valve replacement and mitral valve repair techniques show feasibility but require further comparative evaluation.

    Conclusions:

    • Percutaneous interventions are crucial in managing valvular heart disease, with PMC being a well-established success.
    • Emerging percutaneous valve replacement and repair technologies hold promise, particularly for high-risk patients.
    • Continued research and evaluation are necessary to define the optimal role and expand the application of new percutaneous valve therapies.